MGNX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

MacroGenics (MGNX) Earnings Date & Reports

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MGNX is expected to report earnings to rise 171.67% to -65 cents per share on May 13

Q1'25

Est.

$-0.65

Q4'24

Beat

by $0.16

Q3'24

Beat

by $0.69

Q2'24

Missed

by $0.23

Q1'24

Missed

by $0.20

The last earnings report on March 20 showed earnings per share of -23 cents, beating the estimate of -40 cents. With 468.30K shares outstanding, the current market capitalization sits at 95.90M.

View a ticker or compare two or three

Compare

MGNX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MGNX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in the discovery and development of monoclonal antibody-based therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

9704 Medical Center Drive

Phone

+1 301 251-5172

Employees

339

Web

https://www.macrogenics.com